ERBC (European Research Biology Center)
Luca Beltrami is a seasoned financial professional currently serving as a Financial Controller at the European Research Biology Center since October 2022. Prior experience includes working at EY as a Financial Auditor from September 2019 to October 2022, where responsibilities encompassed managing multiple audit missions across various sectors, ensuring compliance, and enhancing team capabilities. Luca's early career involved roles as a Financial Auditor Intern at EY, a Marketing & Business Unit Controller Intern at L'Oréal, and a Business Analyst Intern at Disneyland Paris, contributing to budgeting, forecasting, and financial analysis. Educational credentials include a master's degree in Financial Audit & Accounting from TBS Education and an advanced diploma in Accounting and Management. Additionally, an exchange program at the W. P. Carey School of Business further enriched Luca's academic background.
This person is not in any offices
ERBC (European Research Biology Center)
Stemming from the merger of two reference CROs in pharmacology and toxicology (CERB and RTC), European Research Biology Center (ERBC) is a European leader in non-clinical studies. It offers to healthcare and chemical professionals a comprehensive range of experimental capabilities, preclinical models, regulatory pre-IND package and consultancy services to de-risk innovation and improve R&D productivity. Based in Baugy (France) and Roma (Italy), ERBC provides all services from preclinical proof-of-concept to market of any type of drug candidate or chemical compound. Each project is managed by a study director, relying on a multi-disciplinary team of experts, notably in general pharmacology, cardiology, electrophysiology and pathophysiology, also benefiting from a world class academic and private network. Every year, study reports from our two Centers are successfully used in support of market authorization and new product approval submissions around the world, including the European (EMA, ECHA), US (FDA and EPA) and Japanese (MHLW and MAFF) regulatory authorities. Investment in outstanding scientific and technical manpower, high-tech equipment and facilities are crucial cornerstones of our sound and organic growth. The quality and reliability of our performance is reflected by the many ongoing and long-lasting collaborations we maintain with leading international pharmaceutical and chemical companies. ERBC is deeply engaged in animal ethics and welfare. ERBC supports the Basel Declaration, respects the 3Rs concept and continually improves its tools and procedures to maximize the balance between the benefit for health and the animal well-being.